India's Non-Small-Cell Lung Cancer Drug Market Will Almost Double by 2013

| |

Distributed by Press Release EMAIL ARTICLE PRINT ARTICLE WALTHAM, Mass. (Map) - Western Branded Drug Sales Will Command 54 percent of the Market by 2013, According to a New Report from Decision Resources WALTHAM, Mass., May 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the non-small-cell lung cancer drug market in India will almost double by 2013, growing from $27.7 million in 2008 to..

0 comments:

Post a Comment